Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin. 2018;68(6):394–424.

Article  Google Scholar 

Hussein MR. Skin cancer in Egypt: a word in your ear. Cancer Biol Ther. 2005;4(5):593–5.

Article  Google Scholar 

Bastian BC. The molecular pathology of melanoma: an integrated taxonomy of melanocytic neoplasia. Annu Rev Pathol. 2014;9:239–71.

Article  CAS  Google Scholar 

Elder DE, Massi D, Scolyer RA, Willemze R. Melanocytic tumours. In: Edkins S, editor. WHO Classification of skin tumours WHO classification of tumours WHO series on the classification of human tumours. Geneva: World Health Organization; 2018.

Google Scholar 

Saroufim M, Habib R, Karram S, Youssef Massad C, Taraif S, Loya A, et al. BRAF analysis on a spectrum of melanocytic neoplasms: an epidemiological study across differing UV regions. Am J Dermatopathol. 2014;36(1):68–73.

Article  Google Scholar 

Chen Z, Gibson TB, Robinson F, Silvestro L, Pearson G, Xu B, et al. MAP kinases. Chem Rev. 2001;101(8):2449–76.

Article  CAS  Google Scholar 

Haling JR, Sudhamsu J, Yen I, Sideris S, Sandoval W, Phung W, et al. Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling. Cancer Cell. 2014;26(3):402–13.

Article  CAS  Google Scholar 

Cheng L, Lopez-Beltran A, Massari F, MacLennan GT, Montironi R. Molecular testing for BRAF mutations to inform melanoma treatment decisions: a move toward precision medicine. Mod Pathol. 2018;31(1):24.

Article  CAS  Google Scholar 

Fisher KE, Cohen C, Siddiqui MT, Palma JF, Lipford EH, Longshore JW. Accurate detection of BRAF pV600E mutations in challenging melanoma specimens requires stringent immunohistochemistry scoring criteria or sensitive molecular assays. Human pathology. 2014;45(11):2281–93.

Article  CAS  Google Scholar 

Capper D, Preusser M, Habel A, Sahm F, Ackermann U, Schindler G, et al. Assessment of BRAF V600E mutation status by immunohistochemistry with a mutation-specific monoclonal antibody. Acta Neuropathol. 2011;122(1):11–9.

Article  CAS  Google Scholar 

Chung JY, Choi J, Sears JD, Ylaya K, Perry C, Choi CH, et al. A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue laboratory investigation. J Tech Methods Pathol. 2016;96(10):1116–27.

CAS  Google Scholar 

Yancovitz M, Litterman A, Yoon J, Ng E, Shapiro RL, Berman RS, et al. Intra- and inter-tumor heterogeneity of BRAF(V600E))mutations in primary and metastatic melanoma. PLoS ONE. 2012;7(1):e29336.

Article  CAS  Google Scholar 

Milne P, Bigley V, Bacon CM, Neel A, McGovern N, Bomken S, et al. Hematopoietic origin of langerhans cell histiocytosis and erdheim-chester disease in adults. Blood. 2017;130(2):167–75.

Article  CAS  Google Scholar 

Frouin E, Maudelonde T, Senal R, Larrieux M, Costes V, Godreuil S, et al. Comparative methods to improve the detection of BRAF V600 mutations in highly pigmented melanoma specimens. PloS ONE. 2016;11:7.

Article  Google Scholar 

Zhang W, Song G, Han X, Li X, Luo D. A validation study for the use VE1 immunohistochemical staining in screening for BRAF mutation in cutaneous malignant melanoma. Biomed Res. 2017;28(11):4886–90.

CAS  Google Scholar 

Anwar MA, Murad F, Dawson E, Abd Elmageed ZY, Tsumagari K, Kandil E. Immunohistochemistry as a reliable method for detection of BRAF-V600E mutation in melanoma: a systematic review and meta-analysis of current published literature. J Surg Res. 2016;203(2):407–15.

Article  CAS  Google Scholar 

Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, et al. Immunohistochemistry is highly sensitive and specific for the detection of V600E BRAF mutation in melanoma. Am J Surg Pathol. 2013;37(1):61–5.

Article  Google Scholar 

Routhier CA, Mochel MC, Lynch K, Dias-Santagata D, Louis DN, Hoang MP. Comparison of 2 monoclonal antibodies for immunohistochemical detection of BRAF V600E mutation in malignant melanoma, pulmonary carcinoma, gastrointestinal carcinoma, thyroid carcinoma, and gliomas. Hum Pathol. 2013;44(11):2563–70.

Article  CAS  Google Scholar 

Ito T, Tanaka Y, Murata M, Kaku-Ito Y, Furue K, Furue M. BRAF heterogeneity in melanoma. Curr Treat Options Oncol. 2021;22(3):20.

Article  Google Scholar 

Reiman A, Kikuchi H, Scocchia D, Smith P, Tsang YW, Snead D, et al. Validation of an NGS mutation detection panel for melanoma. BMC Cancer. 2017;17(1):150.

Article  Google Scholar 

O’Brien O, Lyons T, Murphy S, Feeley L, Power D, Heffron C. BRAF V600 mutation detection in melanoma: a comparison of two laboratory testing methods. J Clin Pathol. 2017;70(11):935–40.

Article  CAS  Google Scholar 

Pisareva E, Gutkina N, Kovalenko S, Kuehnapfel S, Hartmann A, Heinzerling L, et al. Sensitive allele-specific real-time PCR test for mutations in BRAF codon V600 in skin melanoma. Melanoma Res. 2014;24(4):322–31.

Article  CAS  Google Scholar 

Vallée A, Denis-Musquer M, Herbreteau G, Théoleyre S, Bossard C, Denis MG. Prospective evaluation of two screening methods for molecular testing of metastatic melanoma: diagnostic performance of BRAF V600E immunohistochemistry and of a NRAS-BRAF fully automated real-time PCR-based assay. PLoS ONE. 2019;14(8):e0221123.

Article  Google Scholar 

Richter A, Grieu F, Carrello A, Amanuel B, Namdarian K, Rynska A, et al. A multisite blinded study for the detection of BRAF mutations in formalin-fixed, paraffin-embedded malignant melanoma. Sci Rep. 2013;3:1659.

Article  Google Scholar 

Kim SY, Kim SN, Hahn HJ, Lee YW, Choe YB, Ahn KJ. Metaanalysis of BRAF mutations and clinicopathologic characteristics in primary melanoma. J Am Acad Dermatol. 2015;72(6):1036–46.

Article  CAS  Google Scholar 

Bauer J, Büttner P, Murali R, Okamoto I, Kolaitis NA, Landi MT, et al. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 2011;24(2):345–51.

Article  CAS  Google Scholar 

Greaves WO, Verma S, Patel KP, Davies MA, Barkoh BA, Galbincea JM, et al. Frequency and spectrum of BRAF mutations in a retrospective, single-institution study of 1112 cases of melanoma. J Mol Diagn JMD. 2013;15(2):220–6.

Article  CAS  Google Scholar 

Kiuru M, Tartar DM, Qi L, Chen D, Yu L, Konia T, et al. Improving classification of melanocytic nevi: Association of BRAF V600E expression with distinct histomorphologic features. J Am Acad Dermatol. 2018;79(2):221–9.

Article  CAS  Google Scholar 

Inumaru JS, Gordo KI, Fraga Junior AC, Silva AM, Leal CB, Ayres FM, et al. Analysis of the BRAF V600E mutation in primary cutaneous melanoma. Genet Mol Res GMR. 2014;13(2):2840–8.

Article  CAS  Google Scholar 

NCCN Guidelines Version 4. 2020 Cutaneous Melanoma. Accessed 27 Sep2020. 2020 updated Feb. Available from: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_melanoma.pdf.